From CNBC: 2024-04-10 15:37:28

The Denver-Boulder region is becoming a major life sciences hub, with companies developing cutting-edge medical treatments fueled by a surge in funding, venture capital, and demand for lab space.

BioMed Realty recently made headlines with a record-breaking $625 million purchase of Flatiron Park in Boulder for lab and tech space, citing the area’s innovation ecosystem with ample resources.

Investment in Denver-Boulder’s life sciences real estate market is growing rapidly, attracting investors and companies seeking lab space, with a 35% increase in qualified workers over the past five years.

Entrepreneurial success stories like Array BioPharma’s acquisition by Pfizer for $10.64 billion in 2019 and Edgewise Therapeutics’ IPO in 2021 showcase the region’s history of attracting capital and talent.

Denver-Boulder’s innovation ecosystem is vibrant, with research institutions like the University of Colorado’s Anschutz Medical Campus driving drug discovery efforts and cutting-edge technologies to expedite drug development timelines.



Read more at CNBC: Record funding propels Denver-Boulder’s life sciences market